Select for export 347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder No abstract availability was recorded for this entry. Details DOI 10.1016/j.biopsych.2023.02.587 Copy citation Copy BibTeX Biological Psychiatry 2023-04-09 Xi Zhu, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria Gómez, Franklin R. Schneier OpenAlex Published psilocybin DepressionReceptor Pharmacology Other More
Select for export 96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.biopsych.2023.02.336 Copy citation Copy BibTeX Biological Psychiatry 2023-04-09 Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Audrey Shoultz, Trisha Suppes OpenAlex Published psilocybin Depression Other More
Select for export Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231154852 PubMed 36938991 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-03-19 Jordan Sloshower, Patrick D. Skosnik, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020 Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231158245 PubMed 36876583 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-03-05 Emma I Kopra, Jason Ferris, Adam Winstock, Kim P. C. Kuypers, Allan H. Young, James Rucker OpenAlex Published psilocybin PTSDChronic PainReceptor Pharmacology Observational Study More
Select for export The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging Studies Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2023.1948 Copy citation Copy BibTeX European Psychiatry 2023-02-28 J. H. Shepherd, C.T.M. Baten, A. C. Klassen, G. Zamora, Sarah Saravia, Elizabeth Pritchard OpenAlex Published psilocybin Brain ImagingReceptor PharmacologyAging Meta-Analysis More
Select for export Psychedelics for the Neuropsychiatric Symptoms of Alzheimer's disease No abstract availability was recorded for this entry. Details DOI 10.1016/j.jagp.2022.12.201 Copy citation Copy BibTeX American Journal of Geriatric Psychiatry 2023-02-15 Ashish Sarangi, Omotola Akinkunmi OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2023.01.108 PubMed 36740140 Copy citation Copy BibTeX Journal of Affective Disorders 2023-02-02 Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James Bennett, Megan Croal OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export More on psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.12788/cp.0333 Copy citation Copy BibTeX Current Psychiatry 2023-01-31 Aryan Sarparast OpenAlex Published psilocybin General Other More
Select for export Classic psychedelics do not affect T cell and monocyte immune responses Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1042440 PubMed 36741125 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-01-19 Deborah Rudin, Alexander Areesanan, Matthias E. Liechti, Carsten Gründemann OpenAlex Published psilocin End-of-Life DistressPharmacologyReceptor Pharmacology In Vitro Study More
Select for export The association between naturalistic use of psychedelics and co-occurring substance use disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1066369 PubMed 36704738 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-01-09 Jonina Rabinowitz, Shaul Lev-Ran, Raz Gross OpenAlex Published psilocybin AddictionClinical TrialObservational Study Clinical Trial More
Select for export A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245231170340 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Jaden Brandt OpenAlex Published psilocybin Toxicity Other More
Select for export From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia No abstract availability was recorded for this entry. Details DOI 10.1177/20503245231198472 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Octavian Dixon Ritchie, Cameron N Donley, Gabrielle Dixon Ritchie OpenAlex Published psilocybin Toxicity Other More
Select for export Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221140004 PubMed 36588452 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-31 Jack E. Henningfield, Judy Ashworth, David J. Heal, Sharon L. Smith OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221146356 PubMed 36601974 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-31 Matthias Forstmann, Hannes Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Carhart-Harris OpenAlex Published psilocybin AddictionPharmacologyToxicity Other More
Select for export Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-022-25658-5 PubMed 36535992 Copy citation Copy BibTeX Scientific Reports 2022-12-18 Grant Jones, Diego Arias, Matthew K. Nock OpenAlex Published psilocybin Observational StudyAdolescentsToxicity Observational Study More
Select for export “A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0279073 PubMed 36516137 Copy citation Copy BibTeX PLoS ONE 2022-12-13 Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley OpenAlex Published psilocybin DepressionAddictionEmotional Processing Clinical Trial More
Select for export Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221131997 PubMed 36515370 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-13 Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2022.11.046 PubMed 36513161 Copy citation Copy BibTeX Journal of Affective Disorders 2022-12-09 Sarah Shnayder, Rezvan Ameli, Ninet Sinaii, Ann Berger, Manish Agrawal OpenAlex Published psilocybin Chronic PainWellbeingSpirituality Other More
Select for export Psychedelic Drug Legislative Reform and Legalization in the US Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamapsychiatry.2022.4101 PubMed 36477830 Copy citation Copy BibTeX JAMA Psychiatry 2022-12-06 Joshua S. Siegel, James E. Daily, Demetrius A. Perry, Ginger E. Nicol OpenAlex Published psilocybin AgingReview ArticleOlder Adults Review Article More
Select for export Matrix-assisted laser-desorption/ionization-mass spectrometric imaging of psilocybin and its analogues in psychedelic mushrooms using a cesium chloride-coated target plate No abstract availability was recorded for this entry. Details DOI 10.1007/s00216-022-04467-9 PubMed 36459169 Copy citation Copy BibTeX Analytical and Bioanalytical Chemistry 2022-12-01 Hang Wang, Ying Wang OpenAlex Published psilocybin Brain ImagingAgingToxicity Other More
